Pharmacologic treatment of irritable bowel syndrome
Crossref DOI link: https://doi.org/10.1007/s15006-023-2882-3
Published Online: 2023-09-15
Published Print: 2023-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Andresen, Viola
Layer, Peter
Text and Data Mining valid from 2023-09-01
Version of Record valid from 2023-09-01
Article History
First Online: 15 September 2023
Interessenkonflikt
: V.A.: Vorträge und/oder Beratungstätigkeiten für folgende Firmen: Amedes, Bayer, Falk, Ferring, Hexal, KyowaKirin, Medice, Sanofi, Shionogi